Across TCGA pan-cancer cohorts, PABPC1P8 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated PABPC1P8 data layer.
The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher PABPC1P8 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated PABPC1P8 expression acts as an unfavorable survival marker, although some lineages such as STAD and LAML show a favorable association.
LIHC, KIRC, and KIRP are the cancer types where PABPC1P8 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.